Dermatopathology
Simin Shamsi meymandi; Shahriar Dabiri; Alireza ZeynadiniMeymand; Maryam Iranpour; Maryam Khalili; Sorour Alijani; Mahin Aflatoonian
Abstract
Background & Objective:Basal cell carcinoma (BCC) is classified into BCC1 or low risk (nodular, superficial type) and BCC2 or high risk (micronodular, morpheaform, infiltrative, and basosquamous types) based on clinical behavior. This study attempts to evaluate immunohistochemical (IHC) findings ...
Read More
Background & Objective:Basal cell carcinoma (BCC) is classified into BCC1 or low risk (nodular, superficial type) and BCC2 or high risk (micronodular, morpheaform, infiltrative, and basosquamous types) based on clinical behavior. This study attempts to evaluate immunohistochemical (IHC) findings and clinical features associated with local aggressiveness and recurrence in BCC lesions.Methods:This is a cross-sectional descriptive study conducted on 42 paraffin blocks (22 BCC1, 20 in BCC2) at Pathology Department of Afzalipour Teaching Hospital. First, demographic features of the patients were recorded and pathology blocks were classified by two dermatopathologists based on histopathological types of BCC1 and BCC2. Then, primary monoclonal antibodies including CD10, CD1a, SMA, Ki67, CD34, and P53 were utilized for IHC study. We compared BCC1 and BCC2 according to IHC markers, demographic features of patients, and tumoral features.Results:The mean number of Langerhans cells (LCs) within epidermis above tumor mass was 14+1.92 and 4.7±1.23 in BCC1 and BCC2, respectively; these results show a significant difference between the two groups (P=0.001). P53 was positive in 41.13±6.39% and 74.5 ±6.26% of the tumor cells in BCC1 and BCC2 groups, which was statistically significant (P=0.001). Also, the mean number of blood vessels was 14.40±1.30 and 21.40±1.97 in BCC1 and BCC2, that was statistically significant (P=0.005).Conclusion: Higher numbers of angiogenesis (SMA positive) and positive P53 were observed in BCC2 than BCC1. Also, more active positive CD1a cells were observed in BCC1 compared to BCC2.
Dermatopathology
Ruchita Tyagi; Dilpreet Kaur; Gursheen Kaur; Bhavna Garg; Neena Sood; Sunil Gupta
Abstract
Basal cell carcinoma (BCC) commonly affects the elderly and is mostly confined to the head and neck region. Only 10% of all cases occur on the trunk. We presented a case of bullous lesion on the abdomen in a young male, initially diagnosed by clinicians as a vascular nevus. Histopathological examination ...
Read More
Basal cell carcinoma (BCC) commonly affects the elderly and is mostly confined to the head and neck region. Only 10% of all cases occur on the trunk. We presented a case of bullous lesion on the abdomen in a young male, initially diagnosed by clinicians as a vascular nevus. Histopathological examination and immunohistochemistry (IHC) revealed it to be Nodular cystic variant of BCC. This rare variant of BCC morphologically resembles benign skin adnexal tumor of Eccrine syringofibroadenoma. Ber Ep4 positivity on IHC established the correct diagnosis. This case highlights that nodular cystic variant of BCC can be a diagnostic dilemma for clinicians and pathologists.
Oya N. Sivrikoz; Gülşen Kandiloğlu
Abstract
Background and Objective: Clinical behavior of basal cell carcinoma (BCC) is known to be different according to histological growth pattern and basosquamous cell carcinomas (BSC) are known with their aggressive behavior and metastatic capacity. In this study, we evaluated bcl-2 and cyclin D1 expressions ...
Read More
Background and Objective: Clinical behavior of basal cell carcinoma (BCC) is known to be different according to histological growth pattern and basosquamous cell carcinomas (BSC) are known with their aggressive behavior and metastatic capacity. In this study, we evaluated bcl-2 and cyclin D1 expressions in BCC and BSC cases comparatively, to explore their predictive value on the aggressive behavior of these tumors. Methods: One hundred tumors belong to 92 patients diagnosed as basal cell carcinoma and basosquamous carcinoma were studied. Basal cell carcinomas were classified as aggressive and non-aggressive types according to growth pattern. Number of Cyclin D1 and bcl-2 positive cells in immunohistochemically stained serial sections were scored as low (0-1 +) and high (2 and 3+) in all tumors. Results: A statistically significant difference was found between non-aggressive (nodular type) and aggressive types (micronodular, infiltrative types and BSC) for these markers (P<0.005). Cyclin D1 was higher in the aggressive group, while bcl-2 was lower in the aggressive group compared to the non-aggressive group. Conclusion: HigherCyclin D1 and lower bcl-2 scores was correlated with aggressive tumor types and these results could be used as markers to predict aggressive behavior in BCC and BSCs. How to cite this article: Sivrikoz O, Kandiloğlu G. The Effects of Cyclin D1 and Bcl-2 Expressıon on Aggressive Behavior in Basal Cell and Basosquamous Carcinoma. Iran J Pathol. 2015;10(3):185-91.
Shahram Sabeti; Farhad Malekzad; Nastaran Neishaboori; Mihan Pourabdollah Toutkaboni; Farahnaz Bidarizerehpoosh
Volume 9, Issue 4 , October 2014, , Pages 245-250
Abstract
Background & Objectives: CD10 is a cell surface enzyme with metalloendopeptidase activity, also known as Common Acute Lymphoblastic Leukaemia Antigen, which mainly serves as a marker for acute lymphoblastic leukemia (ALL). To date and to the best of our knowledge, only few comparative immunohistochemical ...
Read More
Background & Objectives: CD10 is a cell surface enzyme with metalloendopeptidase activity, also known as Common Acute Lymphoblastic Leukaemia Antigen, which mainly serves as a marker for acute lymphoblastic leukemia (ALL). To date and to the best of our knowledge, only few comparative immunohistochemical studies have assessed CD10 expression in cutaneous epithelial neoplasms. Our goal was to determine whether CD10 can be used in pathologic distinction of cutaneous basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Methods: This study included 27 BCC and 17 SCC cases immunohistochemically stained for CD10. Cytoplasmic +/- cell membrane staining was considered as positive. Each slide was studied by two pathologists and scored semi- quantitatively as follows: negative (<10%); 1+ (10-50% positive cells); and 2+ (>50% positive cells). Results: The rate of CD10 expression in tumor cells was significantly higher in BCCs in comparison to SCCs. (20/27 vs., 2/17; P <0.0001). Discussion: Our findings suggest CD10 as a useful adjunct marker in distinguishing cutaneous BCC and SCC.
Nourieh Sharifi; Mohammad Javad Yazdanpanah
Volume 2, Issue 3 , June 2007, , Pages 97-99
Abstract
Background and Objective: Cutaneous cytology is the study of scraping or smears obtained from skin lesions. Although not commonly employed, cutaneous cytology has been a useful tool for clinicians due to simplified procedures and high sensitivity and specificity of presurgical clinical diagnosis of common ...
Read More
Background and Objective: Cutaneous cytology is the study of scraping or smears obtained from skin lesions. Although not commonly employed, cutaneous cytology has been a useful tool for clinicians due to simplified procedures and high sensitivity and specificity of presurgical clinical diagnosis of common types of skin tumors. This investigation was conducted to study usefulness of cutaneous cytology in diagnosis of basal and squamous cell carcinoma. Methods: We collected 42 skin tumors in total, clinically presumed to be either BCC (n = 31) or SCC (n = 10). Samples were taken by the scraping technique. After smearing the cells onto several glass slides, they were fixed with 96% alcohol. The specimens were stained with Papanicolaou stain. Punch biopsies were taken to confirm the clinical and cytologic impression. Results: Cytodiagnosis and histopathologic examination of 42 cases of BCC (n = 32) and SCC (n = 10) showed a significant concordance between histopathology of skin specimen and cytologic diagnosis with a sensitivity rate of 96.8% and specificity rate of 90% and with a high positive predictive value of 96.8%. Conclusion: Cytologic examination is easy to perform, saves time, and provides a rapid and reliable procedure in diagnosis and confirmation of non-melanoma malignant skin tumors (BCC and SCC).
Parvin Rajabi; Mohammad Aboutalebdokht; Mitra Heidarpour; Ali Asilian; Fatemeh Rajabi
Volume 2, Issue 1 , January 2007, , Pages 7-10
Abstract
Background and Objective: Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are two common tumors of the skin. In some cases, distinction between BCC and SCC can be difficult. This study aimed to clarify this uncertainty through immunohistochemical analysis. In this respect, epithelial membrane ...
Read More
Background and Objective: Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are two common tumors of the skin. In some cases, distinction between BCC and SCC can be difficult. This study aimed to clarify this uncertainty through immunohistochemical analysis. In this respect, epithelial membrane antigen (EMA) and Ber-Ep4 are the two immunohistochemical markers on which we focus in differentiating skin BCC from SCC. Materials and Methods: Archived paraffin-embedded tissue samples of BCC (n = 40) and SCC (n=40) were stained immunohistochemically using Ber-Ep4 and EMA antibodies. Results: It was found out that 37 (92.5%) out of the BCC samples stained positive for Ber-Ep4 and 2.5% of SCC samples showed positive staining. The majority of SCC group (37 out of 40) expressed EMA, while 5% of BCC samples showed positive staining. Conclusion: Distinction of BCC and SCC of the skin can be readily achieved through Ber-Ep4 and EMA immunohistochemical markers. Regarding potential false positive and negative results through immunostaining techniques, we may recommend the use of these two antibodies together.